Timothy C.  Crew net worth and biography

Timothy Crew Biography and Net Worth

CEO of Lannett
Timothy C. Crew was appointed as the Company’s Chief Executive Officer and a Director of the Company in January 2018.  Mr. Crew has more than 30 years of experience in the generic and branded pharmaceutical industries.  Previously, he served as Chief Executive Officer of Cipla North America, a global pharmaceutical company based in Mumbai, India.  Before Cipla, he worked for eight years at Teva Pharmaceuticals Industries Ltd. (“Teva”), where he ultimately served as Senior Vice President and Commercial Operating Officer of the North American Generics division, the world’s largest generic operation with multibillion dollars of annual sales.  Before that, he was Teva’s Vice President, Alliances and Business Development.  Mr. Crew was also an Executive Vice President, North America, for Dr. Reddy’s Laboratories Ltd.  Mr. Crew began his pharmaceutical career at Bristol-Myers Squibb, where he held a number of senior management positions in global marketing, managed healthcare, marketing, business development and strategic planning.  Prior to his pharmaceutical roles, Mr. Crew served in the United States Army, where he rose to the rank of Captain. Mr. Crew earned a Bachelor of Arts degree in economics from Pomona College and a Masters of Business Administration degree from Columbia Business School.

What is Timothy C. Crew's net worth?

The estimated net worth of Timothy C. Crew is at least $0.00 as of June 14th, 2021. Mr. Crew owns 102,764 shares of Lannett stock worth more than $0 as of March 18th. This net worth approximation does not reflect any other assets that Mr. Crew may own. Learn More about Timothy C. Crew's net worth.

How do I contact Timothy C. Crew?

The corporate mailing address for Mr. Crew and other Lannett executives is 9000 STATE ROAD, PHILADELPHIA PA, 19136. Lannett can also be reached via phone at (215) 333-9000. Learn More on Timothy C. Crew's contact information.

Has Timothy C. Crew been buying or selling shares of Lannett?

Timothy C. Crew has not been actively trading shares of Lannett within the last three months. Most recently, on Monday, December 13th, Timothy C. Crew bought 5,000 shares of Lannett stock. The stock was acquired at an average cost of $7.96 per share, with a total value of $39,800.00. Learn More on Timothy C. Crew's trading history.

Who are Lannett's active insiders?

Lannett's insider roster includes Timothy Crew (CEO), Jeffrey Farber (Director), John Kozlowski (CFO), and Patrick Lepore (Director). Learn More on Lannett's active insiders.

Timothy C. Crew Insider Trading History at Lannett

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2021Buy5,000$7.96$39,800.00View SEC Filing Icon  
6/14/2021Buy2,500$20.00$50,000.00102,764View SEC Filing Icon  
9/1/2020Buy750$20.40$15,300.0099,808View SEC Filing Icon  
5/12/2020Buy750$30.28$22,710.0046,934View SEC Filing Icon  
11/11/2019Buy500$35.96$17,980.0046,141View SEC Filing Icon  
8/29/2019Buy500$33.80$16,900.0045,971View SEC Filing Icon  
5/10/2019Buy750$27.40$20,550.0011,939View SEC Filing Icon  
2/11/2019Buy1,000$33.92$33,920.0011,497View SEC Filing Icon  
11/9/2018Buy500$21.40$10,700.009,733View SEC Filing Icon  
8/29/2018Buy500$22.04$11,020.009,562View SEC Filing Icon  
5/10/2018Buy500$58.92$29,460.00View SEC Filing Icon  
See Full Table

Timothy C. Crew Buying and Selling Activity at Lannett

This chart shows Timothy C Crew's buying and selling at Lannett by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Lannett Company Overview

Lannett logo
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $1.54
Low: $0.65
High: $2.51

2 Week Range

Now: N/A

Volume

280,600 shs

Average Volume

92,067 shs

Market Capitalization

$7.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95